Fol. Biol. 2005, 51, 1-2
https://doi.org/10.14712/fb2005051010001
MHC Class I Downregulation, Tumour Escape from Immune Surveillance and Design of Therapeutic Strategies
References
1. , J. (2003a) Prospects for immunotherapy of MHC class I-deficient tumours. Folia Biol. (Praha) 49, 95-99.
2. , J. (2003b) Tumour MHC class I downregulation and immunotherapy. Oncol. Rep. 10, 2005-2008.
3. , J. (2004) MHC class I down-regulation: Tumour escape from immune surveillance? Int. J. Oncol. 25, 487-491.
4. , J., Vonka, V. (2003) MHC class I status of tumours and design of immunotherapeutic strategie. Immunol. Lett. 90, 177-178.
5. , F., Ruiz-Cabello, F., Cabrera, T., Pérez-Villar, J. J., López-Botet, M., Duggan-Keen, M., Stan, P. L. (1997) Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol. Today 18, 89-95.
<https://doi.org/10.1016/S0167-5699(96)10075-X>
6. , D. J., Marincola, F. M., Ferrone, S. (1999) HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. Mol. Med. Today 5, 178-186.
<https://doi.org/10.1016/S1357-4310(99)01451-3>
7. , H. G., Kärre, K. (1990) In search of the „missing self“: MHC molecules and NK cell recognition. Immunol. Today 11, 237-244.
<https://doi.org/10.1016/0167-5699(90)90097-S>
8. , R., Bieblová, J., Šímová, J., Indrová, M., Jandlová, T., Vonka V., Šmahel, M., Bubeník, J., Mendoza, L. (2003) Local IFNγ therapy of HPV16-associated tumours. Folia Biol. (Praha) 49, 26-32.
9. , R., Bubeník, J., Vonka, V., Šmahel, M., Indrová, M., Bieblová, J., Šímová, J., Jandlová, T. (2005) Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy. Int. J. Oncol. 26, 521-527.
10. , R., Van den Burg, S. H., Ossendorf, F., Toes, R. E. M., Melief, C. J. M. (2000) Design of evaluation and antigen-specific vaccination strategies against cancer. Curr. Opin. Immunol. 12, 576-582.
<https://doi.org/10.1016/S0952-7915(00)00145-X>
11. , K., Schenrich, P., Schluter, C., Kronke, M. (1987) Tumor necrosis factor enhances HLA-ABC and HLA-DR gene expression in human tumor cells. J. Immunol. 138, 975-980.
<https://doi.org/10.4049/jimmunol.138.3.975>
12. , D. S., Maguire, J. E. (1990) Regulation of the expression of class I MHC genes. Crit. Rev. Immunol. 10, 235-257.
